CDNA caredx.com Expected net earnings per share growth this year
The annual earnings per share growth rate on the precise GURU.Markets chart is recorded at 207.00. CareDx, Inc (CDNA) is protected from economic crises due to the critical importance of transplant monitoring. CareDx, Inc (CDNA) leads in non-invasive diagnostics, offering an alternative to biopsies through AlloSure tests. The brand is currently successfully restoring the trust of the professional community, strengthening its market position.
Financial and market metric breakdowns for CareDx Health (CDNA)
- current quotes and average value forecast:
- market capitalization data:
- shareholders' equity book value data:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio CareDx, Inc|CDNA - Long-Term Debt to Capital|Current Liabilities to Capital CareDx, Inc.|CDNA - Company Aggregate Debts|Debt to Book Value Ratio CareDx Inc|CDNA - Company Long-Term Liabilities|Company Short-Term Indebtedness CareDx|Intermediate Coverage Ratio caredx.com
- net income and valuation ratios data:
CDNA - Net Profit|Company Profit Forecast CareDx, Inc|CDNA - Price to Earnings Ratio|Price to Future Earnings Ratio CareDx Health|CDNA - PEG Multiple|Enterprise Value to EBITDA Ratio CareDx|CDNA - Operating profit EBITDA|Net earnings per share for the last 12 months CareDx|CDNA - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last 12 months caredx.com|CDNA - Earnings per share growth in current year|Projected earnings per share growth rate for next year CareDx, Inc
- sales volume and revenue information:
Fundamental valuation:CareDx, Inc
CareDx, Inc (CDNA) revenues depend on insurance reimbursements for transplant rejection diagnostics, meaning the current YoY EPS growth reflects the actual monetization efficiency within this medical niche. This indicator measures the annual trend in earnings per share, enabling value investors to identify local price bottoms and generate alpha, provided there is strict control over the business's debt load.
Key competitors
Net earnings per share change in current year Agilent Tech A|Earnings per share growth in current year Quest Corp|Illumina, Inc. (ILMN) - Expected net earnings per share growth this year|Earnings growth in current year EXAS|RVTY (Revvity) - Earnings per share increase in current year|Earnings per share growth in current year bio-rad.com BIO|NNNN: Earnings per share growth this year|Sotera Health Corp - Earnings growth in current year|Expected net earnings per share growth this year QuidelOrtho QDEL|OPK (OPKO Health) - Net earnings per share growth this year|Maravai LifeSciences Corp (MRVI) - Earnings growth in current year|FLGT (fulgentgenetics.com) - Earnings growth in current year|Earnings growth in current year Standard BioTools Corp|Net earnings per share growth this year CTKB (Cytek Biosciences, Inc.)|OSUR (OraSure Technologies) - Earnings per share increase in current year|Earnings growth in current year XGN (exagen.com)|MDxHealth Inc. - Earnings per share growth in current year|Lucid Diagnostics, Inc - Earnings growth in current year|Expected net earnings per share growth this year Prenetics Global Limited PRE|Insight Molecular (IMDX) - Earnings per share growth in current year|TRIB (Trinity Biotech PLC) - Earnings per share growth in current year|Earnings per share growth in current year ProPhase Labs|Ainos (AIMD) - Expected net earnings per share growth this year|Net earnings per share growth this year CODX (Co-Diagnostics)|HSCS (Heart Test Labs) - Earnings per share increase in current year|Earnings per share growth in current year Biomerica BMRA|CDIO: Earnings per share growth this year|Onconetix Inc - Earnings growth in current year|Expected net earnings per share growth this year Virax Biolabs Group Ltd VRAX|bluejaydx.com (BJDX) - Earnings per share growth in current year|Vermillion - Earnings per share increase in current year|AXDX (Accelerate Diagnostics Inc) - Earnings growth in current year|Net earnings per share growth this year CENTOGENE, N.V. (CNTG)|Net earnings per share growth this year ENZ (Enzo)|Earnings growth in current year Fresh2 Group Limited (FRES)|Earnings growth in current year GENE (GTG Labs)|ME - Net earnings per share growth this year|Psychemedics Inc - Earnings growth in current year
